Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6

  1. de Jong, J.
  2. Mitselos, A.
  3. Jurczak, W.
  4. Cordoba, R.
  5. Panizo, C.
  6. Wrobel, T.
  7. Dlugosz-Danecka, M.
  8. Jiao, J.
  9. Sukbuntherng, J.
  10. Ouellet, D.
  11. Hellemans, P.
Aldizkaria:
Pharmacology Research and Perspectives

ISSN: 2052-1707

Argitalpen urtea: 2020

Alea: 8

Zenbakia: 5

Mota: Artikulua

DOI: 10.1002/PRP2.649 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus